$1,170,000 of TENET HEALTHCARE CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) Outpatient Surgery Quality and Access Act Medicaid Fiscal Accountability Regulation (MFAR) ACA premium tax credits Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) Outpatient Surgery Quality and Access Act Medicaid Fiscal Accountability Regulation (MFAR) ACA premium tax credits House and Senate Budgets as pertain to Medicare and Medicaid. Consumer Financial Protection Bureau Rulemaking Tax Reform FTC non-compete rulemaking"
You can find more data on corporate lobbying on Quiver Quantitative.
THC Congressional Stock Trading
Members of Congress have traded $THC stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 04/20, 04/15, 02/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
THC Insider Trading Activity
THC insiders have traded $THC stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- THOMAS W ARNST (EVP, Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 32,000 shares for an estimated $7,527,737.
- R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 8,017 shares for an estimated $1,865,576.
- PAOLA M ARBOUR (EVP, Chief Information Officer) sold 6,500 shares for an estimated $1,549,795
- J ROBERT KERREY has made 0 purchases and 5 sales selling 5,638 shares for an estimated $983,920.
- NADJA WEST sold 3,000 shares for an estimated $532,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
THC Hedge Fund Activity
We have seen 283 institutional investors add shares of THC stock to their portfolio, and 350 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,209,118 shares (+106.5%) to their portfolio in Q1 2026, for an estimated $228,172,657
- AQR CAPITAL MANAGEMENT LLC removed 813,951 shares (-36.1%) from their portfolio in Q1 2026, for an estimated $153,600,693
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 798,825 shares (-34.4%) from their portfolio in Q1 2026, for an estimated $150,746,265
- NUVEEN, LLC removed 675,646 shares (-58.5%) from their portfolio in Q1 2026, for an estimated $127,501,156
- KHROM CAPITAL MANAGEMENT LLC removed 504,279 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $95,162,490
- QUBE RESEARCH & TECHNOLOGIES LTD added 499,399 shares (+324.4%) to their portfolio in Q1 2026, for an estimated $94,241,585
- CAPITAL WORLD INVESTORS added 491,957 shares (+inf%) to their portfolio in Q1 2026, for an estimated $92,837,205
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
THC Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $252.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $240.0 on 07/09/2026
- Ryan Langston from TD Cowen set a target price of $233.0 on 06/22/2026
- Michael Ha from Baird set a target price of $210.0 on 05/05/2026
- Raj Kumar from Stephens & Co. set a target price of $260.0 on 05/04/2026
- Stephen Baxter from Wells Fargo set a target price of $213.0 on 05/01/2026
- Matthew Gillmor from Keybanc set a target price of $225.0 on 05/01/2026
- Jason Cassorla from Guggenheim set a target price of $252.0 on 05/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
